TABLE 5.
Blood Glucose Level of alloxan-induced diabetic mice at different intervals after XSL fractions administration.
| Groups | Dose (mg/kg) | Days after treatment | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 3 | 6 | 9 | 12 | 15 | 18 | ||
| C | 103 ± 9.90a a | 95.5 ± 0.71a a | 97 ± 4.24a a | 91 ± 1.41a a | 94 ± 2.83a a | 96.5 ± 2.12a a | 93 ± 4.24a a | 97 ± 1.41a a | |
| CD | 105 ± 7.07a a | 345 ± 7.07d d | 348 ± 5.66d d | 350 ± 5.66d d | 355 ± 7.07d d | 358 ± 5.66d d | 363 ± 3.54d d | 364 ± 2.12d d | |
| XSCP | 400 | 93.5 ± 0.71a a | 355 ± 7.07 d d | 350 ± 7.07 d d | 339 ± 8.49 c c | 327 ± 9.20 c c | 313 ± 11.3c c | 299 ± 4.95 b b | 278 ± 10.6 b b |
| XSPE | 400 | 97.5 ± 3.54a a | 325 ± 21.2 d c | 323 ± 21.9 cd b | 318 ± 21.9 cd b | 313 ± 21.9 cd b | 305 ± 21.2 c b | 301 ± 22.6c b | 297 ± 26.2 c b |
| XSEA | 400 | 96 ± 2.73a a | 353 ± 10.6 d d | 341 ± 10.6 d cd | 316 ± 7.78 d b | 291 ± 5.66 c b | 267 ± 23.3b b | 250 ± 23.3b b | 220 ± 25.5 b b |
| XSETH | 400 | 99 ± 4.95a a | 327 ± 9.2 d c | 320 ± 7.1 d bc | 312 ± 4.95 d c | 300 ± 7.1d b | 288 ± 10.6c b | 278 ± 13.4 c b | 266 ± 15.6c b |
| XSW | 400 | 112 ± 4.24a a | 316 ± 8.5 d d | 314 ± 9.90 d d | 315 ± 12.73 d d | 310 ± 14.1 c b | 309 ± 14.4 c b | 308 ± 14.1c c | 306 ± 14.1 c c |
The values are mean ± SD, of triplicate experiments, the different letters over each range denote variation (p ≤ 0.05) in blood glucose level at various intervals (superscripted letters) and type of fraction administered (subscript letters).